-+ 0.00%
-+ 0.00%
-+ 0.00%

NanoViricides To Present Data On NV-387 At Pharma Partnering Summit 2025

Benzinga·11/14/2025 13:35:32
Listen to the news

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be presenting today, Friday, November 14th, at 11:25am ET at the Pharma Partnering Summit 2025 held at the Hilton Boston Logan Airport in Boston, MA.